← FDA Drug Approvals (Drugs@FDA)

SUGAMMADEX SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHANDONG · Approved 2023-03-20

Drug application

FDA Application #

ANDA215701

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUGAMMADEX SODIUM

Generic name

Sugammadex Sodium

Active ingredients

SUGAMMADEX SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

None (Tentative Approval)

Sponsor

SHANDONG

First approval

2023-03-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown